Process to enhance the bioactivity of Ashwagandha extracts
The invention relates to an extract of Ashwagandha that exhibit enhanced bioactivity and bioavailability comprising of enriched withanolide glycosides and saponins; with negligible amount of alkaloids, withanolide aglycones and oligosaccharides. The extract as disclosed prepared from root, stems, leaves and whole plant of Ashwagandha further shows improved immunomodulatory activity, anti-inflammatory activity, anti stress activity, antidiabetic activity and sleep quality. The disclosure also provides a method of improving bioactivity of withanolide glycosides even at lower doses, by the administration of an enteric coaled formulation of extract of Ashwagandha to humans. The enteric coaling protects the composition from hydrolysis in the acidic environment of the stomach to release the withanolide glycoside in neutral/alkaline pH in gastrointestinal tract (GIT) thus enhancing the absorption. Further the process of preparation of the extract of Ashwagandha enriched with withanolide glycosides and saponins are disclosed along with various formulations.
1. A method of enhancing bioactivity of an extract of Withania somnifera, the method comprising administering an enteric coated composition of the extract of Withania somnifera to a subject in need thereof, wherein the extract of Withania somnifera comprises at least about 3.5% withanolide glycosides,
wherein an enteric coating for the enteric coated composition of the extract of Withania somnifera is selected from the group consisting of poly (methacrylic acid-co-methyl methacrylate), a combination of modified ethyl cellulose and sodium alginate, and combinations thereof.
2. The method of enhancing bioactivity of the extract of Withania somnifera of claim 1 , the method comprising administering a composition of the extract of Withania somnifera having about 35% withanolide glycosides.
3. The method of enhancing bioactivity of the extract of Withania somnifera of claim 1 , the method comprising administering a composition of the extract of Withania somnifera having about 80% withanolide glycosides.
4. A method of enhancing bioavailability of withanolide glycosides from an extract of Withania somnifera, the method comprising administering an enteric coated composition of the extract of Withania somnifera to a subject in need thereof, wherein the extract of Withania somnifera comprises at least about 3.5% withanolide glycosides,
wherein an enteric coating for the enteric coated composition of the extract of Withania somnifera is selected from the group consisting of poly (methacrylic acid-co-methyl methacrylate), a combination of modified ethyl cellulose and sodium alginate, and combinations thereof.
5. The method of enhancing bioavailability of withanolide glycosides from the extract of Withania somnifera of claim 4 , the method comprising administering a composition of the extract of Withania somnifera having about 35% withanolide glycosides.
6. The method of enhancing bioavailability of withanolide glycosides from the extract of Withania somnifera of claim 4 , the method comprising administering a composition of the extract of Withania somnifera having about 80% withanolide glycosides.
7. A method of delivering an extract of Withania somnifera into a medium having a pH ranging from about 6 to about 9, the method comprising administering an enteric coated composition of the extract of Withania somnifera, whereby the extract of Withania somnifera is released from the enteric coated composition of the extract of Withania somnifera when the pH of the medium ranges from about 6 to about 9, wherein the extract of Withania somnifera comprises at least about 3.5% withanolide glycosides,
wherein an enteric coating for the enteric coated composition of the extract of Withania somnifera is selected from the group consisting of poly (methacrylic acid-co-methyl methacrylate), a combination of modified ethyl cellulose and sodium alginate, and combinations thereof.